Risk factors for nephrotoxicity associated with polymyxin B therapy in Chinese patients
Conclusion This retrospective cohort study identified three risk factors for polymyxin B-associated nephrotoxicity therapy in Chinese patients. These include malignancy, co-infection with other microorganisms, and polymyxin B daily dose.
Source: International Journal of Clinical Pharmacy - Category: Drugs & Pharmacology Source Type: research
More News: Cancer & Oncology | China Health | Drugs & Pharmacology | Multidrug Resistance | Polymyxin B | Statistics | Study